Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | CDK11B |
| Gene Name: | CDK11B |
| Protein Full Name: | Cell division protein kinase 11B |
| Alias: | CD2L1; CDC2L1; CDK11; CDK11-p110; CDK11-p46; CDK11-p58; Cell division cycle 2-like 1; Cell division cycle 2-like protein kinase 1; CLK-1; Galactosyltransferase associated protein kinase p58/GTA; Galactosyltransferase-associated protein kinase p58/GTA; P58 CLK-1; PITSLREA; PK58 |
| Mass (Da): | 92707 |
| Number AA: | 795 |
| UniProt ID: | P21127 |
| Locus ID: | 984 |
| COSMIC ID: | CDK11B |
| Gene location on chromosome: | 1p36.33 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 19535 |
| Percent of cancer specimens with mutations: | 0.17 |
| Normal role description: | CDK11B is a protein-serine/threonine kinase. |